(Q63318847)
Statements
A 4-month, Open-label, Multi-center Study to Explore the Safety and Tolerability of Fingolimod 0.5 mg in Patients With Relapsing-remitting Multiple Sclerosis (English)
0 references
February 2012
0 references
April 2014
0 references
162
0 references
18 year
0 references
65 year
0 references